UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 12B-25
NOTIFICATION OF LATE FILING
Commission File Number 000-29785
(CHECK ONE): [X] FORM 10-K and Form 10-KSB [ ] Form 20-F [ ] Form 11-K
[ ] Form 10-Q [ ] Form N-SAR
For Period Ended: DECEMBER 31, 2001
[ ] Transition Report on Form 10-K
[ ] Transition Report on Form 20-F
[ ] Transition Report on Form 11-K
[ ] Transition Report on Form 10-Q
[ ] Transition Report on Form N-SAR For the Transition Period
Ended: ________________
READ INSTRUCTION (ON BACK PAGE) BEFORE PREPARING FORM. PLEASE PRINT OR TYPE.
NOTHING IN THIS FORM SHALL BE CONSTRUED TO IMPLY THAT THE COMMISSION HAS
VERIFIED ANY INFORMATION CONTAINED HEREIN.
If the notification relates to a portion of the filing checked above, identify
the Item(s) to which the notification relates:
<Page>
PART I -- REGISTRANT INFORMATION
AMERICAN ORIENTAL BIOENGINEERING, INC.
- --------------------------------------------------------------------------------
Full Name of Registrant
INTERNET GOLF ASSOCIATION, INC.
- --------------------------------------------------------------------------------
Former Name if Applicable
12835 EAST ARAPAHOE ROAD #600
- --------------------------------------------------------------------------------
Address of Principal Executive Office (STREET AND NUMBER)
GREENWOOD VILLAGE, COLORADO 80112
- --------------------------------------------------------------------------------
City, State and Zip Code
PART II -- RULES 12B-25(B) AND (C)
If the subject report could not be filed without unreasonable effort or expense
and the Registrant seeks relief pursuant to Rule 12b-25(b), the following should
be completed. (Check box if appropriate)
| (a) The reasons described in reasonable detail in Part III of
| this form could not be eliminated without unreasonable effort
| or expense;
/X/ |
| (b) The subject annual report, semi-annual report, transition
| report on Form 10-K, Form 10-KSB, Form 20-F,11-K or Form
| (N-SAR, or portion thereof, will be filed on or before the
| fifteenth calendar day following the prescribed due date; or
| the subject quarterly report of transition report on Form
| 10- Q, or portion thereof will be filed on or before the fifth
| calendar day following the prescribed due date; and
|
| (c) The accountant's statement or other exhibit required by
| Rule 12b-25(c) has been attached if applicable.
PART III -- NARRATIVE
State below in reasonable detail the reasons why Forms 10-K, Form 10-KSB,
20-F, 11-K, 10-Q, N-SAR, or the transition report portion thereof, could not
be filed within the prescribed time period.
(ATTACH EXTRA SHEETS IF NEEDED)
On December 18, 2001, the Registrant and Harbin Three Happiness
Bioengineering Co., Ltd., a company organized under the laws of the People's
Republic of China, entered into an agreement whereby the Registrant will
acquire 100% of the equity interest of Harbin Bioengineering. In connection
with the agreement, all of the directors and officers of the Registrant prior
to the agreement have resigned and new directors and officers have been
appointed. In light of the agreement and the international operations of the
Registrant on a going-forward basis, the Registrant determined to engage new
auditors and accountants. In light of the changes in the Registrant's
management and accountants/auditors, filing a Form 10-KSB within the
prescribed time period could not be prevented without unreasonable effort or
expense.
PART IV -- OTHER INFORMATION
(1) Name and telephone number of person to contact in regard to this
notification
HOWARD JIANG 212 588-5552
- --------------------- ----------------------------------------------------------
(Name) (Area Code) (Telephone Number)
(2) Have all other periodic reports required under Section 13 or 15(d) of
the Securities Exchange Act of 1934 or Section 30 of the Investment
Company Act of 1940 during the preceding 12
months or for such shorter period that the registrant was required to
file such report(s) been filed? If answer is no, identify report(s).
[YES]
- --------------------------------------------------------------------------------
(3) Is it anticipated that any significant change in results of operations
from the corresponding period for the last fiscal year will be
reflected by the earnings statements to be included in the subject
report or portion thereof? No
If so, attach an explanation of the anticipated change, both narratively and
quantitatively, and, if appropriate, state the reasons why a reasonable estimate
of the results cannot be made.
AMERICAN ORIENTAL BIOENGINEERING, INC.
--------------------------------------------
(Name of Registrant as Specified in Charter)
has caused this notification to be signed on its behalf by the undersigned
hereunto duly authorized.
Date 3/31/02 By /s/ Tony Liu
- ----------------- -----------------------------------
Tony Liu
President and Director
INSTRUCTION: The form may be signed by an executive officer of the Registrant of
by any other duly authorized representative. The name and title of the person
signing the form shall be typed or printed beneath the signature. If the
statement is signed on behalf of the Registrant by an authorized representative
(other than an executive officer), evidence of the representative's authority to
sign on behalf of the Registrant shall be filed with the form.